CAPR
Capricor Therapeutics Inc
9.40$
+10.0%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | |
| 186.9% | 364.3% | 502.9% | 787.5% | 722.0% | 511.6% | 2,725.9% | 100.3% | 855.1% | 144.8% | 224.4% | – | |
| -72.0% | -264.3% | 100.0% | 100.0% | 100.0% | -411.6% | 100.0% | 100.0% | -755.1% | -44.8% | -124.4% | – | |
| 186.9% | 364.3% | 502.9% | 787.5% | 722.0% | 511.6% | 2,725.9% | 5,541.5% | 855.1% | 144.8% | 224.4% | – | |
| 72.4% | 115.8% | 154.6% | 348.4% | 295.1% | 357.9% | 1,786.7% | 3,108.4% | 408.9% | 50.9% | 66.8% | – | |
| 244.4% | 434.0% | 632.2% | 1,040.8% | 1,017.0% | 357.9% | 4,512.6% | 8,649.9% | 408.9% | 50.9% | 66.8% | – | |
| -144.4% | -334.0% | -532.2% | -940.8% | -917.0% | -769.5% | -4,412.6% | -8,549.9% | -1,163.9% | -95.6% | -191.1% | – | |
| 4.8% | 6.6% | 10.8% | 29.2% | 0.0% | 0.0% | 0.0% | 423.8% | 66.5% | – | 0.0% | – | |
| -149.2% | -340.5% | -589.5% | 177.8% | -908.9% | -760.4% | -4,401.9% | -8,175.9% | -1,137.4% | -88.5% | -181.7% | – | |
| 4.8% | 3.6% | 6.9% | 18.6% | 8.1% | -26.3% | -57.0% | -250.5% | 0.0% | 0.0% | – | – | |
| -149.2% | -340.5% | -589.5% | 177.8% | -908.9% | -760.4% | -4,401.9% | -8,175.9% | -1,137.4% | -88.5% | -181.7% | – | |
| -143.4% | -331.1% | -528.2% | -930.2% | -907.6% | -752.4% | -4,366.2% | -8,075.5% | -1,116.5% | -84.3% | -175.3% | – |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.